SHARESIFT
Healthcare · data ~15-min delayed
175.35 AUD -1.62%
| Price | 175.35 AUD |
| Day change | -1.62% |
| Market cap | 84.15B |
| 52-week range | 90 – 222.47 |
| P/E (trailing) | — |
| Dividend yield | 2.31% |
| Payout ratio | 45.49% |
| Return on equity | -15.83% |
| Debt / equity | 67% |
| Beta | 0.13 |
| Sector | Healthcare |
| Value score | 26 / 100 |
CSL Limited (CSL.AX) scores 26/100 on this site's value model, in the lower band: most of the valuation measures it checks sit on the richer side. It is classified in Healthcare. The dividend yield is 2.31%, paid from 45% of earnings. Return on equity is -16%, with debt at 67% of equity. On its filings it passes 3 of the nine Piotroski checks, which points to deteriorating fundamentals. Its Altman Z-Score places it in the safe zone. These are automated readings of reported figures, not a recommendation.
Piotroski F-Score 3 / 9 — nine pass/fail checks on profitability, leverage and efficiency, comparing the latest financial year with the one before.
Altman Z-Score 3.60 — Safe zone.
Updated · prices ~15-min delayed, fundamentals as last reported
Open full interactive analysis →See how it ranks: ASX stocks by value score
Value scoring · Piotroski F-Score · Altman Z · technicals · dividends — free, no sign-up.